Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05439200 · ClinicalTrials.gov registry record · NA

Video Treatment for Amblyopia

A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05439200: Recruiting NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.

NCT05439200 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 44 participants, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05439200, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether viewing asynchronous movies leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to treatment.

Primary Outcome

change in amblyopic eye logMAR visual acuity relative to baseline

Conditions Studied

Interventions

  • DEVICE Asynchronous 3D movies
  • DEVICE Patching

Study Locations (1)

Texas

  • Retina Foundation - Dallas

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2023-08-23
Est. Completion 2027-06-30
Phase NA
Retina Foundation of the Southwest

11 total trials

What NCT05439200 shows while recruiting

NCT05439200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which Asynchronous 3D movies is the first listed.

NCT05439200 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05439200 about?

NCT05439200 is a clinical study titled "Video Treatment for Amblyopia". The purpose of this study is to determine whether viewing asynchronous movies leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to treatment.

What is the current status of trial NCT05439200?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-08-23. Estimated completion is 2027-06-30.

What conditions does trial NCT05439200 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT05439200?

The interventions under investigation include: Asynchronous 3D movies (DEVICE), Patching (DEVICE).

Who is sponsoring clinical trial NCT05439200?

This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05439200 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05439200's enrollment target sits among peer trials

44 19th of 24 higher than 6 of 24 other Amblyopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05439200, the US trial registry maintained by the National Library of Medicine. NCT05439200 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.